πŸ‡ΊπŸ‡Έ FDA
Patent

US 9187426

Organic compounds

granted A61KA61K31/4439A61K31/444

Quick answer

US patent 9187426 (Organic compounds) held by Xenon Pharmaceuticals Inc. expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/4439, A61K31/444, A61P, A61P13/00